Bladder Cancer - Results from #60

Role of Lymphadenectomy During Radical Cystectomy for Non-muscle Invasive Bladder Cancer: Results From a Multi-Institutional Experience. October 27, 2021

Efficacy of Adding Panitumumab to Dose-Dense MVAC Chemotherapy in Patients with Advanced Urothelial Cancer - Expert Commentary October 26, 2021

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study October 26, 2021

Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer. October 26, 2021

Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer. October 26, 2021

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going? October 25, 2021

The Sirenic Links between Diabetes, Obesity, and Bladder Cancer. October 25, 2021

Clinical effect of robot-assisted radical cystectomy in bladder cancer. October 22, 2021

Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start. October 22, 2021

[Rational follow-up of non-muscle invasive bladder cancer]. October 21, 2021

[Transurethral resection of the urinary bladder : Status quo and outlook on new developments]. October 21, 2021

Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group. October 20, 2021

Fighting the 'tobacco epidemic' - A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancer. October 19, 2021

Patients With Muscle Invasive Bladder Cancer with Non-luminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy. October 19, 2021

Emerging roles of autophagy in the development and treatment of urothelial carcinoma of the bladder. October 19, 2021

Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling. October 18, 2021

Incidence and mortality of bacille Calmette-Guérin (BCG) infections after BCG instillation therapy. October 18, 2021

Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses. October 18, 2021

The emerging treatment landscape of advanced urothelial carcinoma. October 15, 2021

Clinicopathologic analysis of patients undergoing repeat transurethral resection of bladder tumour following an initial diagnosis of urothelial carcinoma with lamina propria invasion and variant/divergent histology. October 15, 2021

Page 4 of 412

email news signup